2021 Revenues ($USD) : $1,494,353,963
2021 Revenues (foreign currencies) : SEK kr13,763,000,000
2021 R&D spend : $161,346,363
2021 Number of Employees : 4,194
Fiscal Year End : 4/30/2021
Key People : Gustaf Salford, president and CEO; Johan Adebäck, CFO; Karin Svenske Nyberg, EVP, human resources; Maurits Wolleswinkel, president, Linac solutions and chief product officer; Verena Schiller, president, neuro solutions; John Lapré, president, brachy solutions; Andrew Wilson, president, oncology informatics solutions; Paul Bergström, EVP, global services; Larry Biscotti, EVP, region Americas; Anming Gong, EVP, region China; Jonas Bolander, general counsel and EVP; Habib Nehme. EVP, Turkey, India, Middle East, Africa, APAC and Japan; Lionel Hadjadjeba, president, MR-Linac solutions and acting EVP, region Europe.

About the company: The Swedish company has been a pioneer in precision radiation medicine since its founding in 1972. The company has offices in 120 countries and a listing on Nasdaq Stockholm.  –CN